Your shopping cart is currently empty

FAPy-adenine (4,6-diamino-5-N-formamidopyrimidine) is an oxidised DNA base, and its levels in the brains of Alzheimer's disease patients show an upward trend.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $33 | - | In Stock | |
| 5 mg | Preferential | In Stock | In Stock | |
| 10 mg | Preferential | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $89 | - | In Stock |
| Description | FAPy-adenine (4,6-diamino-5-N-formamidopyrimidine) is an oxidised DNA base, and its levels in the brains of Alzheimer's disease patients show an upward trend. |
| In vitro | In the absence of the external field the FAPy-adenine is able to form pairs with all four canonical nucleic acid bases. In contrast, in the presence of the external field the mispairing abilities of FAPy-adenine become insignificant since the most stable dimers are formed with thymine.[1] |
| In vivo | There is an increased trend in the levels of FAPy-adenine in the AD brain. The nuclear DNA damage by oxygen-derived radicals is increased in Alzheimer's disease and support the concept that the brain is under increased oxidative stress in Alzheimer's disease.[1] |
| Synonyms | 4,6-diamino-5-n-formamidopyrimidine |
| Molecular Weight | 153.14 |
| Formula | C5H7N5O |
| Cas No. | 5122-36-1 |
| Smiles | O=CNC=1C(=NC=NC1N)N |
| Relative Density. | 1.575 g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 15 mg/mL (97.95 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (6.53 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.